Jeng et al. found that the expression of IGF2BP3 was increased in HCC patient samples, which was correlated with alpha-fetoprotein, tumor grade, tumor stage, and metastasis, and that IGF2BP3 depletion could reduce HCC cell motility and invasion [54]. Here, IGF2BP3 is linked to hepatocellular carcinoma.